history of hypertension was directly related to increased growth rate (P ¼ .01). The mean growth rate for RAA was 0.017 6 0.052 cm/y (Fig).
IP239. Spontaneous Isolated Superior Mesenteric Artery Dissection Has Treatment Time Window for Complete Resolution
Yasuhiko Kawaguchi, Hiroshi Mitsuoka, Masanao Nakai, Yujiro Miura, Yasuhiko Terai, Shinnosuke Goto, Yuta Miyano, Fumio Yamazaki. Shizuoka City Shizuoka Hospital, Shizuoka, Japan
Objectives: Spontaneous isolated superior mesenteric artery dissection (SISMAD) is an extremely rare vascular disease but associated with a broad spectrum of clinical pictures. We investigated the relations among three-dimensional morphology of SISMAD, presence of symptoms on presentation, and clinical outcomes.
Methods: SISMAD cases (27 male patients) from 2010 to 2016 were retrospectively analyzed. Average follow-up period was 21.3 months. Twelve presented with acute abdominal symptoms. Two severely symptomatic cases due to total occlusion of SMA trunk underwent emergent SMA stenting and resulted in complete resolution of SISMAD. The other 10 symptomatic patients were hospitalized and strictly observed using anticoagulant, antiplatelet, or antihypertensive drugs. Fifteen patients were categorized as asymptomatic, and had been monitored using computed tomography imaging. Length of dissection (l) and false luminal diameter (FD) at the level of lesion with the maximally dilated diameter (MD) were measured. The dissection patterns were classified according to Sakamoto and Zerbib classification. For statistical comparisons, the differences with P values <.05 were regarded as significant.
Results: The asymptomatic cases had a larger percentage of type I dissection patterns of the aforementioned classification. The symptomatic cases had significantly longer length of dissection than asymptomatic cases (l ¼ 72.7 6 17.1 vs 50.9 6 24.8; P ¼ .02) Significant difference was also detected in the true luminal diameters (TD: 4.20 6 2.08 and 6.21 6 2.18; P ¼ .03, Fig 1) . During the observational period, no patient experienced stented lesion occlusion and stenosis, bowel ischemic complications, or aneurysmal rupture. The complete resolution (6 patients) was more frequently detected in the symptomatic patients (P ¼ .02). Significant differences in MD and F/MD between the symptomatic and asymptomatic patients were not detected at each observation time point. However, F/MD of symptomatic patients cases significantly decreased on the final observation (P ¼ .04, Fig 2) .
Conclusions: Severity of SISMAD is related to length of the lesion, false luminal pressure, and the mesenteric ischemia. The time-course of SIS-MAD without a critically severe level symptom seemed benign. Whether it was invasive or conservative, the earlier intervention resulted in better clinical and morphological outcomes.
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IP241. Elective Revascularization for Chronic Mesenteric Ischemia Results in Lower Health Care Costs and Lower Mortality Compared to Emergent Revascularization
Khanjan H. Nagarsheth, Viktor Y. Dombrovskiy, Saum Rahimi. Rutgers University, New Brunswick, NJ Objectives: When nonelective revascularization is performed for chronic mesenteric ischemia (CMI), there is a high reported mortality and rate of complications. In order to identify trends in techniques and outcomes of mesenteric revascularization over time, we performed a database review.
Methods: Using the International Classification of Diseases-Ninth Revision diagnosis code 557.1 and appropriate procedure codes in the Nationwide Inpatient Sample (2007 Sample ( -2014 , we selected patients with CMI who underwent revascularization. Outcomes between those with elective (EL) and nonelective (NEL) hospitalization were compared using c 2 test, Cochran-Armitage trend test, multivariable logistic regression analysis, and Wilcoxon rank sum test.
Results: During the study time, we estimated nationally 12,021 hospitalizations with CMI and revascularization: 4161 EL and 7860 NEL. Postoperative mortality in NEL (5.7%) was almost twice that in EL (3.0%; P < .0001). In both groups, mortality after open surgery (EL: 5.0%; NEL: 16.8%) was higher than after endovascular repair (EL: 1.5%; NEL: 3.6%; P < .0001). From 2007 to 2014, hospital mortality steadily significantly decreased in both EL (from 6.6% to 2.3%; P < .0001) and NEL (from 8.4% to 5.3%; P ¼ .004) but still was considerably greater in those with NEL admissions. Nonelective hospitalizations were significantly longer (median 7 [interquartile range {IQR} 4-12] days vs 5 [IQR 1-8] days; P < .0001) and more expensive (median $21, 923 [IQR $15, 853] vs $17, 577 [IQR $12,057-$26,612; P < .0001) than EL admissions. NEL patients were more likely than EL patients (OR [odds ratio], 3.1; 95% CI [confidence interval], 2.24-4.19) to need bowel resection after revascularization. In the multivariable logistic regression analysis with adjustment for patient age, gender, race, comorbidities, type of admission, and procedure, NEL were still 4.4 times as likely as EL (95% CI, 3.17-6.15) to have bowel resection. Likelihood of bowel resection was also greater after open surgery compared to endovascular repair (OR, 2.9; 95% CI, 2.24-3.72), in males (OR, 1.4; 95% CI, 1.07-1.76), and in African Americans compared to whites (OR, 1.7; 95% CI, 1.09-2.65). 
